140 Intracoastal Pointe Drive, Suite 404
Jupiter, Florida 33477-5094 USA
C1 Technology Solutions
Enable rapid gene discovery. Accelerate product development. Bring gene products to market faster. Dyadic’s proprietary C1 technology is used for gene discovery, host optimization, large-scale manufacturing, and the creation of new products for diverse markets such as animal feed, pulp and paper, food, beverages, textiles, biofuels, biochemicals and biopharmaceuticals.
Develop advanced dependable bioenergy solutions. Identify novel enzymes that convert biomass into fermentable sugars for use in producing biofuels. Bring more cost-effective alternative fuel solutions to market faster. Dyadic’s C1 technology creates new development opportunities, through licensing arrangements and partnerships.
Break the bottlenecks in your genomic research and development programs. Accelerate product development. Improve production yields. Dyadic is interested in forming strategic partnerships to discover biomaterials, lower your costs, develop new products and bring them to market quickly.
Go from gene discovery to commercial manufacturing using the same host microorganism. Use Dyadic enzymes for large-scale production of innovative products. Dyadic delivers the C1 platform technology and more than 50 enzyme products to customers worldwide.
Welcome to Dyadic. We are a global biotechnology company with patented and proprietary technologies that are used to discover, develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries. Dyadic’s C1 platform technology enables the development and large scale manufacture of low cost enzymes and other proteins for diverse market opportunities. Dyadic leverages the value of its technologies through licensing arrangements and other collaborations with third parties who receive the benefits of producing and using the proteins these technologies help produce. LEARN MORE
November 13, 2014
Dyadic International Reports Q3 2014 Financial Results Click Here
November 13, 2014
Dyadic Q3 Financial Conference Call Replay Click Here
November 12, 2014
New U.S. Patent Issued to Dyadic International Click Here
December 7 - 9, 2014
Dyadic's Chief Operating Officer Danai Brooks speaks at Bio Pacific Rim Summit on Industrial Biotechnology and Bioenergy in San Diego, CA Session 3: Monday, December 8 2:30pm-4:00pm Click Here
Mark Emalfarb Interview at LD Micro VI Los Angeles, December 3-5, 2013